Structure Therapeutics Inc - American Depositary Shares —— 财务报表 (NASDAQ:GPCR) | MetaTrader

展开完整图表

新闻

Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?

Structure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy

Structure Therapeutics: A High-Risk, High-Reward Bet On The Next GLP-1 Blockbuster (GPCR)

NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?

Eli Lilly's Experimental Drug Retatrutide Delivers Strong Weight Loss In Late-Stage Trial

Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum?

BMO上调Structure Therapeutics目标价,看好其减肥药数据

BMO raises Structure Therapeutics stock price target on obesity drug data

Structure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition Target (GPCR)

H.C. Wainwright下调Structure Therapeutics目标价,基于市场渗透率假设调整

H.C. Wainwright lowers Structure Therapeutics price target on penetration assumptions

公民金融重申Structure Therapeutics股票评级,基于减重数据